Michael Ganetsky
Overview
Explore the profile of Michael Ganetsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Levine M, Brent J, Wiegand T, Maguire B, Cohen N, Vaerrier D, et al.
Clin Toxicol (Phila)
. 2023 Sep;
61(8):584-590.
PMID: 37655788
Background: Despite conflicting data, intravenous lipid emulsion has emerged as a potential antidote. The "lipid sink" theory suggests that following intravenous administration of lipid, lipophilic drugs are sequestered in the...
2.
Watson C, Ganetsky M, Burke R, Dizitzer Y, Leventhal E, Boyle K
J Med Toxicol
. 2021 Apr;
17(3):265-270.
PMID: 33821434
Background: Prescription drug monitoring programs (PDMPs) exist in 49 states to guide opioid prescribing. In 40 states, clinicians must check the PDMP prior to prescribing an opioid. Data on mandated...
3.
Overbeek D, Watson C, Castaneda N, Ganetsky M
J Med Toxicol
. 2021 Feb;
17(2):218-221.
PMID: 33528767
The COVID-19 pandemic has triggered outbreaks of unanticipated toxicities, including methanol toxicity. Multiple methanol outbreaks have been described, including contaminated hand sanitizer in the southwest USA. In this case, we...
4.
Barash J, Whitledge J, Watson C, Boyle K, Lim C, Lev M, et al.
J Neurol Sci
. 2020 Aug;
417:117048.
PMID: 32739497
Objective: An opioid-associated amnestic syndrome (OAS) characterized by acute onset memory loss and bilateral hippocampal signal abnormalities on brain imaging in the setting of a history of opioid use, most...
5.
Watson C, Whitledge J, Barbuto A, Boyle K, Ganetsky M
Int Anesthesiol Clin
. 2020 Jan;
58(2):19-27.
PMID: 31904630
No abstract available.
6.
Ganetsky M, Berg A, Solano J, Salhanick S
Clin Toxicol (Phila)
. 2019 Dec;
58(8):804-812.
PMID: 31818152
This study examines the metabolomic profile in humans following acetaminophen (APAP) induced subclinical hepatoxicity in the presence and absence of propylene glycol (PG), a cytochrome P450 2E1 inhibitor. Plasma samples...
7.
Watson C, Zettervall S, Hall M, Ganetsky M
Clin Pract Cases Emerg Med
. 2019 Nov;
3(4):390-394.
PMID: 31763596
Direct oral anticoagulants are now commonplace, and reversal agents are recently becoming available. Andexanet alfa (AnXa), approved by the United States Food and Drug Administration in 2018, is a novel...
8.
Ganetsky M, Berg A, Solano J, Salhanick S
J Clin Pharmacol
. 2018 Aug;
59(1):131-138.
PMID: 30151903
Acetaminophen (APAP)-induced liver injury is initiated by metabolism of APAP by the cytochrome P-450 (CYP) system, primarily CYP2E1. We previously demonstrated CYP inhibition following administration of a liquid APAP formulation...
9.
10.
Barash J, Ganetsky M, DeMaria Jr A
N Engl J Med
. 2018 Jun;
378(23):2247-2248.
PMID: 29874536
No abstract available.